Newborn affected by maternal use of alcohol
ICD-10 P04.3 is a billable code used to indicate a diagnosis of newborn affected by maternal use of alcohol.
P04.3 refers to newborns who are affected by maternal alcohol consumption during pregnancy. This condition can lead to a spectrum of disorders known as Fetal Alcohol Spectrum Disorders (FASD), which may include physical, behavioral, and learning problems. Newborns may present with growth deficiencies, facial dysmorphisms, and neurodevelopmental issues. The effects of alcohol can be transmitted through the placenta, impacting fetal development and leading to complications such as low birth weight, preterm birth, and developmental delays. In addition to the immediate physical effects, these infants may require long-term follow-up for developmental assessments and interventions. Accurate coding is essential for tracking the incidence of these conditions and ensuring appropriate care and resources are allocated for affected infants.
Detailed maternal history, including substance use, prenatal care records, and newborn assessment findings.
Newborns presenting with growth restriction, neurodevelopmental delays, or facial anomalies in the NICU.
Consideration of the full spectrum of FASD and the need for interdisciplinary care plans.
Comprehensive developmental assessments and follow-up care documentation.
Pediatric visits for developmental delays or behavioral issues stemming from prenatal alcohol exposure.
Long-term monitoring for developmental milestones and potential learning disabilities.
Used when assessing a newborn affected by maternal alcohol use.
Document maternal history and newborn assessment findings.
Neonatologists should ensure comprehensive evaluations are performed.
Documentation must include a detailed maternal history of alcohol use, newborn assessment findings, and any associated conditions or complications to support the diagnosis.
